Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hypoglycemia (Locemia)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
Description

A treatment for severe hypoglycemia in people with diabetes treated with insulin. The drug uses a proprietary glucagon nasal powder formulation that is delivered in an emergency situation using a single-use, ready-to-use device.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 8505 Chemin Dalton
  • Montreal, Quebec H4T CA
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Hypoglycemia (Locemia)’s full profile, request a free trial.

Hypoglycemia (Locemia) Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Corporate Asset Purchase 09-Oct-2015 Completed
To view this company’s complete deal history including valuation and funding, request access »

Hypoglycemia (Locemia) Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Locemia Solutions Corporation Majority 000 0000 000000 0